RareSearch logo

The Wistar Institute Proteomics Facility

50+ personnel
Headquartered in Chandler
Established in 2025
Website
Morris Douglas profile

Morris Douglas

🇬🇧 United Kingdom

9

    Reviewed:

  • - Clinical Protocol Design
  • - 6 weeks April - May 2023
  • - Pharmaceutical Company

Comprehensive protocol design, very detailed and precise.

The protocol design provided was comprehensive and very detailed. It laid a strong foundation for our clinical trial, ensuring that all regulatory and ethical considerations were addressed. The attention to detail was impressive.

Allen Kunde Jr. profile

Allen Kunde Jr.

🇧🇷 Brazil

8.9

    Reviewed:

  • - Stability Studies
  • - 18 months January 2023 - June 2024
  • - Pharmaceutical Company

Accurate and reliable stability studies, clear reporting.

The stability studies were conducted with precision, and the reporting was clear and thorough. The results provided us with the necessary data to proceed with our regulatory submissions confidently.

Marion Boehm PhD profile

Marion Boehm PhD

🇮🇹 Italy

9.1

    Reviewed:

  • - Pharmacovigilance Services
  • - Ongoing
  • - Pharmaceutical Company

Highly effective pharmacovigilance services, ensured compliance.

The pharmacovigilance services ensured that our post-market surveillance was compliant and effective. The team was proactive in monitoring and reporting, providing us with peace of mind and ensuring patient safety.

Laura Blick profile

Laura Blick

🇳🇱 Netherlands

9

    Reviewed:

  • - Biomarker Development
  • - 12 weeks October 2023 - January 2024
  • - Research Institution

Efficient and precise biomarker development.

The biomarker development project was managed efficiently, with precise results that met our project objectives. The team's expertise in biomarker research was invaluable, and we were impressed with the quality of the deliverables.

Ms. Shari Okuneva profile

Ms. Shari Okuneva

🇫🇷 France

9.3

    Reviewed:

  • - Market Access Strategy
  • - 6 weeks January - February 2024
  • - Pharmaceutical Company

Strategic market access analysis, insightful recommendations.

The market access analysis provided strategic insights that were crucial to our launch strategy. The team's recommendations were data-driven and actionable, helping us to make informed decisions.

Paul Jones profile

Paul Jones

🇯🇵 Japan

9.3

    Reviewed:

  • - Project Management
  • - 10 weeks July - September 2023
  • - Biotech Company

Seamless project management, results exceeded expectations.

Project management was seamless, and the team exceeded our expectations. They handled all aspects of the project with professionalism and efficiency, keeping us informed every step of the way.

April Witting IV profile

April Witting IV

🇰🇷 South Korea

9.4

    Reviewed:

  • - Health Technology Assessment
  • - 10 weeks September - November 2023
  • - Pharmaceutical Company

Thorough and insightful health technology assessment.

The health technology assessment was thorough and provided valuable insights that were critical to our decision-making process. The team demonstrated a deep understanding of the health economics involved and delivered a well-rounded analysis.

Francis Ebert profile

Francis Ebert

🇦🇺 Australia

8.8

    Reviewed:

  • - Companion Diagnostics Development
  • - 16 weeks January - May 2024
  • - Pharmaceutical Company

High-quality companion diagnostics development, delivered on time.

The development of companion diagnostics was of high quality, and the project was delivered on time. The team's technical expertise and understanding of the regulatory environment were key to the success of the project.